Live Breaking News & Updates on Business Development At Sanofi

Stay updated with breaking news from Business development at sanofi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Syncona : OMass Therapeutics Announces Appointment of New Board Chair and Series B Extension

Jim Geraghty joins as Independent Director and Chair, bringing US and international experience from Genzyme and as NED and chair of multiple listed biotechs

British Patient. | May 15, 2023 ....

United Kingdom , James Jim Geraghty , Jim Geraghty , Genzyme Europe , Ros Deegan , Carol Robinson , Rosamond Deegan , Yale Law School , Oxford Science Enterprises , Canbridge Pharmaceuticals , Business Development At Sanofi , Prudential Regulation Authority , British Patient Capital , Consilium Strategic Communications , Financial Conduct Authority , British Business Bank , Pieris Pharmaceuticals , Independent Director , Patient Capital , Northpond Ventures , Sanofi Ventures , Lewis La Torre , Future Fund , Non Executive Director , Orchard Therapeutics , Voyager Therapeutics ,